To access this element change to forms mode OFF
Grant Award View - GA276550
Development of new treatment options for post-sepsis acute lung injury...
GA ID:
GA276550
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$989,098.96
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Development of new treatment options for post-sepsis acute lung injury (ALI).
Purpose:
Acute lung injury (ALI) occurs due to uncontrolled inflammation and is a major cause of death in Australia because there are no treatments. We recently found treatment with a new protein called A3 protects mice from this condition. In this project, we will develop A3 into a new class of anti-inflammatory drug and test it in mouse models of ALI that resemble human ALI and validate our results in human cells. This invention will address one of the most important unmet clinical needs worldwide.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2020151
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Kensington
Town/City:
Kensington
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW
Postcode:
Multiple
Country:
AUSTRALIA